{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:59:24Z","timestamp":1792645164269,"version":"4.5.0"},"reference-count":179,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2022.11124","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T13:17:13Z","timestamp":1641388633000},"source":"Crossref","is-referenced-by-count":82,"title":["Update on the etiopathogenesis of psoriasis (Review)"],"prefix":"10.3892","volume":"23","author":[{"given":"Daciana","family":"Branisteanu","sequence":"first","affiliation":[{"name":"Department of Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Cojocaru","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Railway Clinical Hospital, 700506 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Diaconu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Railway Clinical Hospital, 700506 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Porumb","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Sf. Spiridon\u2019 Clinical Emergency County Hospital, 700111 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisia","family":"Alexa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alin","family":"Nicolescu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Roma\u2019 Medical Center for Diagnosis and Treatment, 011773 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilarie","family":"Brihan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Dermatology Clinic, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Bogdanici","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Branisteanu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Dimitriu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Arcadia\u2019 Hospitals and Medical Centers, 700620 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihail","family":"Zemba","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta","family":"Anton","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Toader","sequence":"additional","affiliation":[{"name":"Department of Oral Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Grechin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, \u2018Sf. Spiridon\u2019 Clinical Emergency County Hospital, 700111 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Branisteanu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"issue":"7488","key":"key20220302115711_b1-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207488","article-title":"New treatment addressing the pathogenesis of psoriasis","volume":"21","author":"Tokuyama","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20220302115711_b2-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"key20220302115711_b3-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"key20220302115711_b4-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: A systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b5-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"m1590","key":"key20220302115711_b6-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"key20220302115711_b7-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"adv00030","key":"key20220302115711_b8-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3384","article-title":"Psoriasis and Genetics","volume":"100","author":"Dand","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"key20220302115711_b9-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3899\/jrheum.190119","article-title":"The genetics of psoriasis and psoriatic arthritis","volume":"(Suppl 95)","author":"O'Rielly","year":"2019","journal-title":"J Rheumatol"},{"key":"key20220302115711_b10-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1046\/j.1473-2165.2002.00406.x","article-title":"The Koebner phenomenon: Review of the literature","volume":"16","author":"Weiss","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20220302115711_b11-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4103\/0378-6323.45100","article-title":"Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria","volume":"74","author":"Malhotra","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"key20220302115711_b12-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/j.1365-4632.2010.04570.x","article-title":"The role of drugs in the induction and\/or exacerbation of psoriasis","volume":"49","author":"Basavaraj","year":"2010","journal-title":"Int J Dermatol"},{"key":"key20220302115711_b13-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.clindermatol.2007.08.015","article-title":"Triggering psoriasis: The role of infections and medications","volume":"25","author":"Fry","year":"2007","journal-title":"Clin Dermatol"},{"key":"key20220302115711_b14-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2230.2000.00588.x","article-title":"Alcohol, smoking and psoriasis","volume":"25","author":"Higgins","year":"2000","journal-title":"Clin Exp Dermatol"},{"issue":"e54","key":"key20220302115711_b15-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2012.26","article-title":"The association between psoriasis and obesity: A systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2012","journal-title":"Nutr Diabetes"},{"issue":"600","key":"key20220302115711_b16-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2013-101505","article-title":"Effect of weather and environmental factors on the clinical course of psoriasis","volume":"70","author":"Balato","year":"2013","journal-title":"Occup Environ Med"},{"key":"key20220302115711_b17-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/1346-8138.13157","article-title":"Effect of a family history of psoriasis and age on comorbidities and quality of life in patients with moderate to severe psoriasis: Results from the ARIZONA study","volume":"43","author":"L\u00f3pez-Estebaranz","year":"2016","journal-title":"J Dermatol"},{"key":"key20220302115711_b18-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/0190-9622(93)70206-9","article-title":"Psoriasis in Australian twins","volume":"29","author":"Duffy","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"key20220302115711_b19-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/hmg\/6.5.813","article-title":"Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis","volume":"6","author":"Trembath","year":"1997","journal-title":"Hum Mol Genet"},{"key":"key20220302115711_b20-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/j.0022-202X.2004.22607.x","article-title":"Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population","volume":"122","author":"Sagoo","year":"2004","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b21-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/bjd.16083","article-title":"HLA-Cw6 and psoriasis","volume":"178","author":"Chen","year":"2018","journal-title":"Br J Dermatol"},{"key":"key20220302115711_b22-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"497","DOI":"10.4103\/0019-5154.87128","article-title":"Hla-a and Hla-B alleles associated in psoriasis patients from Mumbai, Western India","volume":"56","author":"Umapathy","year":"2011","journal-title":"Indian J Dermatol"},{"key":"key20220302115711_b23-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"key":"key20220302115711_b24-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"key":"key20220302115711_b25-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/gene.2008.55","article-title":"Detailed genetic characterization of the interleukin-23 receptor in psoriasis","volume":"9","author":"Garcia","year":"2008","journal-title":"Genes Immun"},{"issue":"479","key":"key20220302115711_b26-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00479","article-title":"Expanding diversity in molecular structures and functions of the IL-6\/IL-12 heterodimeric cytokine Family","volume":"7","author":"Hasegawa","year":"2016","journal-title":"Front Immunol"},{"key":"key20220302115711_b27-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am J Hum Genet"},{"key":"key20220302115711_b28-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/j.1365-2036.2011.04866.x","article-title":"Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: A new series and a review of 120 cases from the literature","volume":"34","author":"Cullen","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"key20220302115711_b29-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/apt.13352","article-title":"Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study","volume":"42","author":"Pugliese","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"key20220302115711_b30-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/pde.13081","article-title":"Psoriasis and psoriasiform eruptions in pediatric patients with inflammatory bowel disease treated with Anti-tumor necrosis factor alpha agents","volume":"34","author":"Eickstaedt","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"key20220302115711_b31-ETM-0-0-11124","first-page":"939","article-title":"Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: Case report and review of 142 cases","volume":"12","author":"Famenini","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"e11185","key":"key20220302115711_b32-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011185","article-title":"Association between psoriasis and vitamin D: Duration of disease correlates with decreased vitamin D serum levels: An observational case-control study","volume":"97","author":"Filoni","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"key20220302115711_b33-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jaad.2012.01.040","article-title":"Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: A case-control study","volume":"67","author":"Orgaz-Molina","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"key20220302115711_b34-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.3892\/etm.2019.7933","article-title":"Association between personality type, affective distress profile and quality of life in patients with psoriasis vs. patients with cardiovascular disease","volume":"18","author":"Porumb-Andrese","year":"2019","journal-title":"Exp Ther Med"},{"key":"key20220302115711_b35-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"key20220302115711_b36-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-4632.2011.05154.x","article-title":"The roles of cells and cytokines in the pathogenesis of psoriasis","volume":"51","author":"Coimbra","year":"2012","journal-title":"Int J Dermatol"},{"key":"key20220302115711_b37-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.rdc.2015.07.013","article-title":"Etiology and pathogenesis of psoriasis","volume":"41","author":"Boehncke","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"key20220302115711_b38-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.it.2008.12.003","article-title":"AMPed up immunity: How antimicrobial peptides have multiple roles in immune defense","volume":"30","author":"Lai","year":"2009","journal-title":"Trends Immunol"},{"key":"key20220302115711_b39-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/1346-8138.14139","article-title":"Pathogenesis of psoriasis and development of treatment","volume":"45","author":"Ogawa","year":"2018","journal-title":"J Dermatol"},{"issue":"1475","key":"key20220302115711_b40-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20220302115711_b41-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.0022-202X.2004.22719.x","article-title":"S100 proteins in the epidermis","volume":"123","author":"Eckert","year":"2004","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b42-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.clindermatol.2007.08.016","article-title":"Innate immunity and antimicrobial defense systems in psoriasis","volume":"25","author":"B\u00fcchau","year":"2007","journal-title":"Clin Dermatol"},{"key":"key20220302115711_b43-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"},{"key":"key20220302115711_b44-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1523-1747.ep12294284","article-title":"Psoriasin: A novel chemotactic protein","volume":"107","author":"Jinquan","year":"1996","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b45-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1189\/jlb.0704409","article-title":"Psoriatic scales: A promising source for the isolation of human skin-derived antimicrobial proteins","volume":"77","author":"Harder","year":"2005","journal-title":"J Leukoc Biol"},{"key":"key20220302115711_b46-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1346-8138.2011.01483.x","article-title":"Antimicrobial peptides in the pathogenesis of psoriasis","volume":"39","author":"Morizane","year":"2012","journal-title":"J Dermatol"},{"key":"key20220302115711_b47-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"15258","DOI":"10.1074\/jbc.272.24.15258","article-title":"The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders","volume":"272","author":"Frohm","year":"1997","journal-title":"J Biol Chem"},{"key":"key20220302115711_b48-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"key20220302115711_b49-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/jid.2011.259","article-title":"Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 Ligands","volume":"132","author":"Morizane","year":"2012","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b50-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaci.2010.12.009","article-title":"Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17\/Th1 T-cell responses","volume":"127","author":"H\u00e4nsel","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"key20220302115711_b51-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.jid.2016.04.033","article-title":"Binding affinity and interaction of LL-37 with HLA-C*06:02 in psoriasis","volume":"136","author":"Mabuchi","year":"2016","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b52-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J Exp Med"},{"key":"key20220302115711_b53-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1084\/jem.21213insight3","article-title":"An autoimmune \u2018attack\u2019 on melanocytes triggers psoriasis and cellular hyperplasia","volume":"212","author":"Krueger","year":"2015","journal-title":"J Exp Med"},{"key":"key20220302115711_b54-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.4049\/jimmunol.1300348","article-title":"Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation","volume":"191","author":"Nishimoto","year":"2013","journal-title":"J Immunol"},{"issue":"E179","key":"key20220302115711_b55-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010179","article-title":"Scanning the immunopathogenesis of psoriasis","volume":"19","author":"Chiricozzi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20220302115711_b56-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/exd.13378","article-title":"Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes","volume":"26","author":"Fuentes-Duculan","year":"2017","journal-title":"Exp Dermatol"},{"issue":"244","key":"key20220302115711_b57-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.4172\/2376-0427.1000244","article-title":"Cutaneous expression of A Disintegrin-like and Metalloprotease domain containing thrombospondin type 1 motif-like 5 (ADAMTSL5) in psoriasis goes beyond Melanocytes","volume":"3","author":"Bonifacio","year":"2016","journal-title":"J Pigment Disord"},{"key":"key20220302115711_b58-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors","volume":"23","author":"Liu","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"key20220302115711_b59-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000495291","article-title":"Psoriasis: Keratinocytes or immune cells-which is the trigger?","volume":"235","author":"Benhadou","year":"2019","journal-title":"Dermatology"},{"key":"key20220302115711_b60-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"key":"key20220302115711_b61-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.0022-202X.2003.22113.x","article-title":"In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered","volume":"122","author":"van der Fits","year":"2004","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b62-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1001\/archderm.140.12.1490","article-title":"Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors","volume":"140","author":"Gilliet","year":"2004","journal-title":"Arch Dermatol"},{"key":"key20220302115711_b63-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/bjd.13236","article-title":"Aldara\u00ae-induced skin inflammation: Studies of patients with psoriasis","volume":"172","author":"Vinter","year":"2015","journal-title":"Br J Dermatol"},{"key":"key20220302115711_b64-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"key20220302115711_b65-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature03547","article-title":"Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"issue":"5621","key":"key20220302115711_b66-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat Commun"},{"key":"key20220302115711_b67-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2133.2011.10301.x","article-title":"Interferon-\u03b1 in the generation of monocyte-derived dendritic cells: Recent advances and implications for dermatology","volume":"165","author":"Farkas","year":"2011","journal-title":"Br J Dermatol"},{"key":"key20220302115711_b68-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20220302115711_b69-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses","volume":"204","author":"Zaba","year":"2007","journal-title":"J Exp Med"},{"key":"key20220302115711_b70-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/jid.2008.225","article-title":"Resident and \u2018inflammatory\u2019 dendritic cells in human skin","volume":"129","author":"Zaba","year":"2009","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b71-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jid.2016.11.033","article-title":"Dynamic changes in resident and infiltrating epidermal dendritic cells in active and resolved psoriasis","volume":"137","author":"Martini","year":"2017","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b72-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.it.2005.10.003","article-title":"Understanding the IL-23-IL-17 immune pathway","volume":"27","author":"McKenzie","year":"2006","journal-title":"Trends Immunol"},{"key":"key20220302115711_b73-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/sj.jid.5700310","article-title":"Prominent production of IL-20 by CD68+\/CD11c+ myeloid-derived cells in psoriasis: Gene regulation and cellular effects","volume":"126","author":"Wang","year":"2006","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b74-ETM-0-0-11124","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archderm.1991.01680050115015","article-title":"The cytokine network in psoriasis","volume":"127","author":"Nickoloff","year":"1991","journal-title":"Arch Dermatol"},{"key":"key20220302115711_b75-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"issue":"e2737","key":"key20220302115711_b76-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002737","article-title":"Type I interferon: Potential therapeutic target for psoriasis?","volume":"3","author":"Yao","year":"2008","journal-title":"PLoS One"},{"key":"key20220302115711_b77-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2133.1991.tb14774.x","article-title":"Psoriasis induced by interferon-alpha","volume":"125","author":"Funk","year":"1991","journal-title":"Br J Dermatol"},{"key":"key20220302115711_b78-ETM-0-0-11124","first-page":"107","article-title":"Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B","volume":"15","author":"Ketikoglou","year":"2005","journal-title":"Eur J Dermatol"},{"key":"key20220302115711_b79-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1365-2133.2010.10124.x","article-title":"Imiquimod 5% cream induced psoriasis: A case report, summary of the literature and mechanism","volume":"164","author":"Patel","year":"2011","journal-title":"Br J Dermatol"},{"key":"key20220302115711_b80-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"key20220302115711_b81-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/s1074-7613(00)00064-9","article-title":"CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha\/beta signaling","volume":"13","author":"Hida","year":"2000","journal-title":"Immunity"},{"key":"key20220302115711_b82-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: A comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"key":"key20220302115711_b83-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/1523-1747.ep12371679","article-title":"The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response","volume":"101","author":"Uyemura","year":"1993","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b84-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.3892\/etm.2019.8008","article-title":"Aspects concerning patient adherence to anti-TNF\u03b1 therapy in psoriasis: A decade of clinical experience","volume":"18","author":"Mocanu","year":"2019","journal-title":"Exp Ther Med"},{"key":"key20220302115711_b85-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jaad.2007.09.010","article-title":"Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"key20220302115711_b86-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1365-2133.2005.06688.x","article-title":"A global phase III randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction","volume":"152","author":"Papp","year":"2005","journal-title":"Br J Dermatol"},{"key":"key20220302115711_b87-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/jdv.15258","article-title":"Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: Pooled analysis of week 16 data from three randomized controlled trials","volume":"33","author":"Blauvelt","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20220302115711_b88-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"key20220302115711_b89-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.4049\/jimmunol.180.3.1913","article-title":"Identification of cellular pathways of \u2018type 1,\u2019 Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis","volume":"180","author":"Haider","year":"2008","journal-title":"J Immunol"},{"key":"key20220302115711_b90-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on psoriasis immunopathogenesis and targeted immunotherapy","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin Immunopathol"},{"key":"key20220302115711_b91-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3892\/etm.2020.8535","article-title":"Inflammatory marker alteration in response to systemic therapies in psoriasis","volume":"20","author":"Grechin","year":"2020","journal-title":"Exp Ther Med"},{"key":"key20220302115711_b92-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1084\/jem.20060244","article-title":"IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"Chan","year":"2006","journal-title":"J Exp Med"},{"key":"key20220302115711_b93-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1073\/pnas.0409569102","article-title":"Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris","volume":"102","author":"Chamian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20220302115711_b94-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.4049\/jimmunol.1001001","article-title":"IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A","volume":"186","author":"Rizzo","year":"2011","journal-title":"J Immunol"},{"key":"key20220302115711_b95-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"key20220302115711_b96-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.4049\/jimmunol.1001538","article-title":"Cutting edge: A critical functional role for IL-23 in psoriasis","volume":"185","author":"Tonel","year":"2010","journal-title":"J Immunol"},{"key":"key20220302115711_b97-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b98-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1046\/j.1523-1747.1998.00419.x","article-title":"Identification and quantitation of interferon-gamma Producing T cells in psoriatic lesions: Localization to Both CD4+ and CD8+ Subsets","volume":"111","author":"Szabo","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"13466","key":"key20220302115711_b99-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13466","article-title":"IL-12 protects from psoriasiform skin inflammation","volume":"7","author":"Kulig","year":"2016","journal-title":"Nat Commun"},{"key":"key20220302115711_b100-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMoa062382","article-title":"A human interleukin-12\/23 monoclonal antibody for the treatment of psoriasis","volume":"356","author":"Krueger","year":"2007","journal-title":"N Engl J Med"},{"key":"key20220302115711_b101-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1080\/15384101.2019.1653099","article-title":"Skin immunity and its dysregulation in psoriasis","volume":"18","author":"Lanna","year":"2019","journal-title":"Cell Cycle"},{"key":"key20220302115711_b102-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1523-1747.ep12514646","article-title":"Characterization of skin-infiltrating lymphocytes in patients with psoriasis","volume":"96","author":"Nikaein","year":"1991","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b103-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0002-9440(10)65109-7","article-title":"Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis","volume":"155","author":"Nickoloff","year":"1999","journal-title":"Am J Pathol"},{"key":"key20220302115711_b104-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1067\/mjd.2000.107945","article-title":"Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: Results of a pilot, multicenter, multiple-dose, placebo-controlled study","volume":"43","author":"Gottlieb","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"key20220302115711_b105-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b106-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b107-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/jid.2009.65","article-title":"Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: Implications for psoriasis pathogenesis","volume":"129","author":"Harper","year":"2009","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b108-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1046\/j.1523-1747.1998.00347.x","article-title":"Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes","volume":"111","author":"Teunissen","year":"1998","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b109-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b110-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol Rev"},{"key":"key20220302115711_b111-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/09674845.2016.1207869","article-title":"Immunophenotyping of T cells in the peripheral circulation in psoriasis","volume":"73","author":"Priyadarssini","year":"2016","journal-title":"Br J Biomed Sci"},{"key":"key20220302115711_b112-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis-results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N Engl J Med"},{"key":"key20220302115711_b113-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMc1610828","article-title":"Phase 3 trials of Ixekizumab in Moderate-to-Severe plaque psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"N Engl J Med"},{"key":"key20220302115711_b114-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jaad.2018.03.037","article-title":"Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial","volume":"79","author":"Papp","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"key20220302115711_b115-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMoa1503824","article-title":"Phase 3 studies comparing brodalumab with ustekinumab in psoriasis","volume":"373","author":"Lebwohl","year":"2015","journal-title":"N Engl J Med"},{"key":"key20220302115711_b116-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/jid.2008.85","article-title":"T-Helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and Psoriasis","volume":"128","author":"Blauvelt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b117-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1056\/NEJMoa1607017","article-title":"Risankizumab versus Ustekinumab for Moderate-to-severe plaque psoriasis","volume":"376","author":"Papp","year":"2017","journal-title":"N Engl J Med"},{"key":"key20220302115711_b118-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2165\/11538950-000000000-00000","article-title":"New interleukin-23 pathway inhibitors in dermatology: Ustekinumab, briakinumab, and secukinumab","volume":"12","author":"Kurzeja","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"key20220302115711_b119-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1517\/14712598.2015.1084284","article-title":"Targeting the IL-23\/IL-17 axis for the treatment of psoriasis and psoriatic arthritis","volume":"15","author":"Alunno","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"key20220302115711_b120-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1365-2133.2012.11168.x","article-title":"Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: A Phase 2b randomized placebo-controlled dose-ranging study","volume":"167","author":"Papp","year":"2012","journal-title":"Br J Dermatol"},{"key":"key20220302115711_b121-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/NEJMoa1806382","article-title":"Phase 2 Trial of selective tyrosine kinase 2 inhibition in psoriasis","volume":"379","author":"Papp","year":"2018","journal-title":"N Engl J Med"},{"key":"key20220302115711_b122-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/bjd.14403","article-title":"A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1\/JAK2 inhibitor, in patients with moderate-to-severe psoriasis","volume":"174","author":"Papp","year":"2016","journal-title":"Br J Dermatol"},{"key":"key20220302115711_b123-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nri954","article-title":"The lineage decisions of helper T cells","volume":"2","author":"Murphy","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"key20220302115711_b124-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<358::AID-PATH253>3.0.CO;2-8","article-title":"IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production","volume":"187","author":"Wei","year":"1999","journal-title":"J Pathol"},{"key":"key20220302115711_b125-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/sj.jid.5701064","article-title":"Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome","volume":"128","author":"Haider","year":"2008","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b126-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nm1605","article-title":"Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis","volume":"13","author":"Conrad","year":"2007","journal-title":"Nat Med"},{"key":"key20220302115711_b127-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1189\/JLB.0109046","article-title":"IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines","volume":"86","author":"Ortega","year":"2009","journal-title":"J Leukoc Biol"},{"key":"key20220302115711_b128-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1517\/14728222.2014.997710","article-title":"IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity","volume":"19","author":"Liang","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"key20220302115711_b129-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/cdd.2017.170","article-title":"Anti-apoptotic BCL-2 family members in development","volume":"25","author":"Opferman","year":"2018","journal-title":"Cell Death Differ"},{"key":"key20220302115711_b130-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/cdd.2017.159","article-title":"BCL2 and miR-15\/16: From gene discovery to treatment","volume":"25","author":"Pekarsky","year":"2018","journal-title":"Cell Death Differ"},{"key":"key20220302115711_b131-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/cdd.2017.183","article-title":"Why do BCL-2 inhibitors work and where should we use them in the clinic?","volume":"25","author":"Montero","year":"2018","journal-title":"Cell Death Differ"},{"key":"key20220302115711_b132-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/15384101.2016.1259892","article-title":"Loss of TGF-\u03b2 signaling drives cSCC from skin stem cells-More evidence","volume":"16","author":"Rose","year":"2017","journal-title":"Cell Cycle"},{"key":"key20220302115711_b133-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1080\/15384101.2018.1482150","article-title":"TNF-\u03b1 induces autophagy through ERK1\/2 pathway to regulate apoptosis in neonatal necrotizing enterocolitis model cells IEC-6","volume":"17","author":"Yuan","year":"2018","journal-title":"Cell Cycle"},{"key":"key20220302115711_b134-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/1523-1747.ep12371752","article-title":"T cells involved in psoriasis vulgaris belong to the Th1 subset","volume":"102","author":"Schlaak","year":"1994","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b135-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/09629350310001619753","article-title":"Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity","volume":"12","author":"Jacob","year":"2003","journal-title":"Mediators Inflamm"},{"key":"key20220302115711_b136-ETM-0-0-11124","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archderm.1990.01670270083013","article-title":"Psoriasis induced at the injection site of recombinant interferon gamma: Results of immunohistologic investigations","volume":"126","author":"Fierlbeck","year":"1990","journal-title":"Arch Dermatol"},{"key":"key20220302115711_b137-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.4049\/jimmunol.1302313","article-title":"Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis","volume":"192","author":"Cheuk","year":"2014","journal-title":"J Immunol"},{"key":"key20220302115711_b138-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1046\/j.0022-202x.2001.01548.x","article-title":"Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions","volume":"117","author":"Lin","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"1214","key":"key20220302115711_b139-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01214","article-title":"Niches for the long-term maintenance of tissue-resident memory T cells","volume":"9","author":"Takamura","year":"2018","journal-title":"Front Immunol"},{"key":"key20220302115711_b140-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.autrev.2018.03.014","article-title":"Pathogenic role of tissue-resident memory T cells in autoimmune diseases","volume":"17","author":"Wu","year":"2018","journal-title":"Autoimmun Rev"},{"key":"key20220302115711_b141-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.4049\/jimmunol.176.7.4431","article-title":"The vast majority of CLA+ T cells are resident in normal skin","volume":"176","author":"Clark","year":"2006","journal-title":"J Immunol"},{"key":"key20220302115711_b142-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.4049\/jimmunol.1200402","article-title":"Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues","volume":"188","author":"Casey","year":"2012","journal-title":"J Immunol"},{"key":"key20220302115711_b143-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/ni.2744","article-title":"The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin","volume":"14","author":"Mackay","year":"2013","journal-title":"Nat Immunol"},{"issue":"625","key":"key20220302115711_b144-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020625","article-title":"Immunological memory of psoriatic lesions","volume":"21","author":"Owczarczyk Saczonek","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20220302115711_b145-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.coi.2018.03.017","article-title":"Transcriptional programming of tissue-resident memory CD8+ T cells","volume":"51","author":"Milner","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"F1000 Faculty Rev-770","key":"key20220302115711_b146-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7927.1","article-title":"Recent advances in understanding psoriasis","volume":"5","author":"Eberle","year":"2016","journal-title":"F1000Res"},{"issue":"166","key":"key20220302115711_b147-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00166","article-title":"A Perspective on the interplay of ultraviolet-radiation, skin microbiome and skin resident memory TCR\u03b1\u03b2+ cells","volume":"5","author":"Patra","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"269rv1","key":"key20220302115711_b148-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci Transl Med"},{"issue":"332","key":"key20220302115711_b149-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00332","article-title":"Tissue-Resident T Cells: Dynamic players in skin immunity","volume":"5","author":"Mueller","year":"2014","journal-title":"Front Immunol"},{"issue":"1904","key":"key20220302115711_b150-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01904","article-title":"The Emerging Role of CD8+ tissue resident memory T (TRM) cells in antitumor immunity: A unique functional contribution of the CD103 integrin","volume":"9","author":"Corgnac","year":"2018","journal-title":"Front Immunol"},{"key":"key20220302115711_b151-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2019.06.002","article-title":"Significance of IL-17A-producing CD8+CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course","volume":"95","author":"Kurihara","year":"2019","journal-title":"J Dermatol Sci"},{"key":"key20220302115711_b152-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"946","DOI":"10.4049\/jimmunol.1900052","article-title":"The functional requirement for CD69 in establishment of resident memory CD8 + T cells varies with tissue location","volume":"203","author":"Walsh","year":"2019","journal-title":"J Immunol"},{"key":"key20220302115711_b153-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.4049\/jimmunol.1402256","article-title":"Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention","volume":"194","author":"Mackay","year":"2015","journal-title":"J Immunol"},{"key":"key20220302115711_b154-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"key20220302115711_b155-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines Tissue-resident CD8+ T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"key":"key20220302115711_b156-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cei.13189","article-title":"Skin resident memory CD8+ T cells are phenotypically and functionally distinct from circulating populations and lack immediate cytotoxic function","volume":"194","author":"Seidel","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"key20220302115711_b157-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrrheum.2016.74","article-title":"CD8(+) T cells in human autoimmune arthritis: The unusual suspects","volume":"12","author":"Petrelli","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"key20220302115711_b158-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/art.41172","article-title":"Tissue-resident memory T cells: Sequestered immune sensors and effectors of inflammation in Spondyloarthritis","volume":"72","author":"Ritchlin","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"key20220302115711_b159-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/nm.3962","article-title":"Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma","volume":"21","author":"Adachi","year":"2015","journal-title":"Nat Med"},{"key":"key20220302115711_b160-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clim.2017.04.001","article-title":"Blood to skin recirculation of CD4+ memory T cells associates with cutaneous and systemic manifestations of psoriatic disease","volume":"180","author":"Diani","year":"2017","journal-title":"Clin Immunol"},{"key":"key20220302115711_b161-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing \u03b1\u03b2 T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J Clin Invest"},{"key":"key20220302115711_b162-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaci.2015.10.046","article-title":"Targeting CD8+ T cells prevents psoriasis development","volume":"138","author":"Meglio","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"key20220302115711_b163-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: Generation, compartmentalization and homeostasis","volume":"14","author":"Farber","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"key20220302115711_b164-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis Factor-alpha","volume":"199","author":"Boyman","year":"2004","journal-title":"J Exp Med"},{"key":"key20220302115711_b165-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: A biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"key20220302115711_b166-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.jid.2018.02.030","article-title":"Resident T cells in resolved psoriasis steer tissue responses that stratify clinical outcome","volume":"138","author":"Gallais S\u00e9r\u00e9zal","year":"2018","journal-title":"J Invest Dermatol"},{"key":"key20220302115711_b167-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jaci.2018.08.048","article-title":"A skewed pool of resident T cells triggers psoriasis-associated tissue responses in never-lesional skin from patients with psoriasis","volume":"143","author":"S\u00e9r\u00e9zal","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"key20220302115711_b168-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bjd.17748","article-title":"CD8 resident memory T cells with interleukin 17A-producing potential are accumulated in disease-na\u00efve nonlesional sites of psoriasis possibly in correlation with disease duration","volume":"181","author":"Vo","year":"2019","journal-title":"Br J Dermatol"},{"issue":"e7692024","key":"key20220302115711_b169-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7692024","article-title":"T Helper cell subsets in clinical manifestations of psoriasis","volume":"2016","author":"Diani","year":"2016","journal-title":"J Immunol Res"},{"key":"key20220302115711_b170-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ajpath.2013.04.021","article-title":"Inhibition of CCR7\/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis","volume":"183","author":"Bos\u00e8","year":"2013","journal-title":"Am J Pathol"},{"key":"key20220302115711_b171-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2019.06.001","article-title":"Protective and pathogenic roles of resident memory T cells in human skin disorders","volume":"95","author":"Watanabe","year":"2019","journal-title":"J Dermatol Sci"},{"key":"key20220302115711_b172-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaut.2016.03.019","article-title":"A role for CCR5(+)CD4 T cells in cutaneous psoriasis and for CD103(+) CCR4(+) CD8 Teff cells in the associated systemic inflammation","volume":"70","author":"Sgambelluri","year":"2016","journal-title":"J Autoimmun"},{"key":"key20220302115711_b173-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41423-019-0291-4","article-title":"Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders","volume":"17","author":"Chen","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"1347","key":"key20220302115711_b174-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01347","article-title":"Metabolic reprogramming and longevity of tissue-resident memory T cells","volume":"9","author":"Pan","year":"2018","journal-title":"Front Immunol"},{"key":"key20220302115711_b175-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08097","article-title":"Enhancing CD8 T-cell memory by modulating fatty acid metabolism","volume":"460","author":"Pearce","year":"2009","journal-title":"Nature"},{"key":"key20220302115711_b176-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2015.03.021","article-title":"IL-7-induced glycerol transport and TAG synthesis promotes memory CD8+ T cell longevity","volume":"161","author":"Cui","year":"2015","journal-title":"Cell"},{"key":"key20220302115711_b177-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature21379","article-title":"Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism","volume":"543","author":"Pan","year":"2017","journal-title":"Nature"},{"issue":"e12730","key":"key20220302115711_b178-ETM-0-0-11124","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12730","article-title":"Redox imbalance and IL-17 responses in memory CD4+ T cells from patients with psoriasis","volume":"89","author":"Esmaeili","year":"2019","journal-title":"Scand J Immunol"},{"key":"key20220302115711_b179-ETM-0-0-11124","doi-asserted-by":"publisher","first-page":"236","DOI":"10.5455\/medarh.2014.68.236-238","article-title":"Immunophenotype lymphocyte of peripheral blood in patients with psoriasis","volume":"68","author":"Karamehic","year":"2014","journal-title":"Med Arch"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T09:57:22Z","timestamp":1646215042000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2022.11124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":179,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,1,5]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2022.11124","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"article-number":"201"}}